Target antigen expression on a professional antigen-presenting cell induces superior proliferative antitumor T-cell responses via chimeric T-cell receptors.
about
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cellsVirus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastomaAdoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells.Early transduction produces highly functional chimeric antigen receptor-modified virus-specific T-cells with central memory markers: a Production Assistant for Cell Therapy (PACT) translational application.Personalized cell transfer immunotherapy for B-cell malignancies and solid cancersAntitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastomaThe ganglioside antigen G(D2) is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting.Immunotherapy of malignant disease using chimeric antigen receptor engrafted T cellsConstruction and preclinical evaluation of an anti-CD19 chimeric antigen receptor.Genetic redirection of T cells for cancer therapy.Chimeric antigen receptor-engineered T cells for immunotherapy of cancer.CD28 co-stimulation via tumour-specific chimaeric receptors induces an incomplete activation response in Epstein-Barr virus-specific effector memory T cells.The combination of cyclophosphamide and human T cells genetically engineered to target CD19 can eradicate established B-cell lymphoma.Characterization of an artificial antigen-presenting cell to propagate cytolytic CD19-specific T cells.
P2860
Q29620717-6FF98616-D5C2-46CB-98FE-2F3A152DEB24Q29622835-C39681B0-255F-42C0-B279-F54A906721A4Q34310912-88D02054-5FB8-4CDA-B3AA-697DA49F1294Q35136456-CB1EB824-6390-48F7-BE3C-B790ECFA9E61Q35568556-EE4FFF21-A9AC-4BF9-8286-460A29F586EFQ35604043-1962302B-64A3-401E-B644-E0A0F7C673CEQ35832365-E9D087C7-8D79-4630-B8E2-27EE4CB847BFQ36470354-D98CEA6A-9B91-4865-9434-76C03F2EA8C5Q37354362-99E2FA78-5199-410A-948A-0AD3BE498EF5Q37697337-869C36BD-35FD-47FC-AB86-12B525211EA9Q37751873-00DC822C-E9EB-4C93-A0DF-2E7C20982277Q45416113-D66B8ACE-36D6-41E8-9158-4FDA96885C03Q47710513-CB5B1D99-0D9C-49B9-A431-96681B613AB5Q53593741-DD410EA8-2D9E-48A1-AA5E-2E2C6C32939F
P2860
Target antigen expression on a professional antigen-presenting cell induces superior proliferative antitumor T-cell responses via chimeric T-cell receptors.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Target antigen expression on a ...... via chimeric T-cell receptors.
@en
type
label
Target antigen expression on a ...... via chimeric T-cell receptors.
@en
prefLabel
Target antigen expression on a ...... via chimeric T-cell receptors.
@en
P2093
P1476
Target antigen expression on a ...... via chimeric T-cell receptors.
@en
P2093
Annette Bär
Claudia Rossig
Cliona M Rooney
Heribert Jürgens
Josef Vormoor
Malcolm K Brenner
Sibylle Pscherer
P356
10.1097/01.CJI.0000175492.28723.D6
P577
2006-01-01T00:00:00Z